Led by researchers at RCSI (Royal College of Surgeons in Ireland), a team of researchers has developed a new treatment for tuberculosis (TB). This work could offer a practical treatment that has the potential to be scaled-up and mass-produced for clinical testing.
The treatment, which patients will take using an inhaler, works by reducing the bacteria in the lungs that causes tuberculosis while also helping the patient’s immune system fight the disease.
There is only one vaccine for tuberculosis, developed in 1921. It is unreliable in preventing the most common form of TB, and is not suitable in all patient groups. The vaccine works best against specific forms of TB and is usually given to infants in at-risk populations.
Tuberculosis is one of the top 10 causes of death worldwide. The World Health Organization (WHO) data show that 10 million people fell ill with TB and 1.6 million died from the disease in 2017. WHO estimates that there were 558,000 new cases with resistance to the most effective first-line antibiotic. Of those resistant to the drug, 82% were resistant to multiple antibiotics.
Funded by the Health Research Board (HRB) and the Royal City of Dublin Hospital Trust, the research is published in the European Journal of Pharmaceutics & Biopharmaceutics.
The work, led by Dr Gemma O’Connor and Prof Sally-Ann Cryan in RCSI, was carried out in collaboration with research teams in St James Hospital, Trinity College Dublin and Imperial College London. Prof Joseph Keane and Dr Mary O’Sullivan led the team at St James Hospital and Trinity College Dublin with Dr Brian Robertson and Dr Nitya Krishnan leading the team at Imperial College London.
Multidrug-resistant TB (MDR-TB) is seen as both a public health crisis and a health security threat. Ending the TB epidemic by 2030 is listed among the health targets of the United Nations Sustainable Development Goals.
The pathogen that causes tuberculosis spreads by people breathing infected droplets into their lungs, where the disease can remain dormant or spread further. The research makes use of a derivative of Vitamin A called all trans retinoic acid, atRA, which previous studies have shown is an effective treatment for tuberculosis.
“Many cases of TB are now becoming resistant to existing antibiotics. This new treatment could be used alongside antibiotics to treat drug-resistant TB and also possibly reduce the rate of antibiotic resistance resulting from conventional antibiotic treatments,” said Prof Cryan, Associate Professor of Pharmaceutics in RCSI School of Pharmacy and the study’s senior author.
Using a spray-drying process, the researchers packaged atRA within safe-for-consumption particles that are small enough to use in an inhaler. These particles efficiently delivered the treatment and significantly reduced tuberculosis-causing bacteria and associated lung damage, which supports their potential for clinical testing.
“Unfortunately, tuberculosis remains a significant problem for world health. We urgently need innovative treatments like this one if we are to achieve the UN 2030 health targets,” said Prof Keane, Professor at Trinity College Dublin School of Medicine and Consultant Respiratory Physician in St James’s Hospital.
The Latest on: Tuberculosis
[google_news title=”” keyword=”tuberculosis” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Tuberculosis
- Fighting the flu: The surprising power of a century-old vaccine for tuberculosison February 22, 2024 at 7:46 am
As Canada's flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses. Scholars from the Research ...
- An Analysis Of Prehistoric Bones Unearthed In Hungary In 1932 Revealed That Neanderthals Living In Central Europe Suffered From Tuberculosis Over 35,000 Years Agoon February 21, 2024 at 6:00 am
Around 35,000 years ago, Neanderthals living in Central Europe suffered from tuberculosis. The new finding has left scientists wondering whether the disease played a part in the extinction of the ...
- Victorian diseases: Nurse killed by Tuberculosis found out just hours before she diedon February 21, 2024 at 12:59 am
There has been a surge in cases of Victorian diseases including Tuberculosis, scabies, measles and rickets in the UKVictorian diseases long believed to be conditions of the past are making a comeback ...
- Mass. town says it’s ‘not facing a public health crisis’ amid tuberculosis concernson February 20, 2024 at 8:37 am
A Massachusetts town says it’s “not facing a public health crisis” amid the recent rise in concerns over tuberculosis cases that have popped up.
- Tuberculosis case reported at Arkansas high schoolon February 19, 2024 at 10:12 pm
SPRINGDALE, Ark. (KAIT) - Arkansas health officials confirmed a case of tuberculosis was found at a high school in the state. According to content partner KNWA, the case was confirmed to be at the ...
- ‘Healthy’ nurse, 30, found out she had tuberculosis just hours before she died and sent chilling 10-word text to familyon February 19, 2024 at 9:42 am
A NURSE found out she had tuberculosis less than 24 hours before she passed away. Carrianne Franks, 30, contracted the deadly Victorian disease while volunteering on an NHS ward in November 2020.
- Tuberculosis confirmed at high school in Arkansas, ADH sayson February 18, 2024 at 6:05 pm
SPRINGDALE, Ark. — A tuberculosis (TB) case has been confirmed at Har-Ber High School, according to the Arkansas Department of Health's (ADH) communications director. Meg Mirivel with ADH shared the ...
- Tuberculosis Rebounds in England, Threatens Eradication Pushon February 16, 2024 at 2:58 pm
Tuberculosis cases in England jumped 11% last year, rebounding to a level higher than before the Covid-19 pandemic. The new figures, based on provisional data from the UK Health Security Agency, adds ...
- No additional CCSD tuberculosis cases identified after case found at schoolon February 16, 2024 at 4:49 am
The Southern Nevada Health District said no additional tuberculosis were found after one active case at a local school.
- Bukit Merah hawkers, shop owners to receive $250 cash assistance after businesses were hit by tuberculosis scareon February 15, 2024 at 8:07 pm
Bukit Merah hawkers and shop owners will be getting $250 in cash relief by end February following tuberculosis cases and screening by MOH. Read on.
via Bing News